IL6 and type 2 diabetes mellitus: Hence, it is noteworthy that chronic systemic inflammation has a key role in the pathophysiology of T2DM and RA [43], which can be explained by the elevated levels of inflammatory mediators such as C-reactive protein (CRP) and interleukin (IL)-6 in patients with RA [44], similar to T2DM [45].